Deciphering the tRNA-dependent lipid aminoacylation systems in bacteria: Novel components and structural advances

References

• Roy H. Tuning the properties of the bacterial membrane with aminoacylated phosphatidylglycerol. IUBMB Life. 2009;61:940–53. doi:10.1002/iub.240.
   PubMed Web of Science ®Google Scholar
• Geiger O, Gonzalez-Silva N, Lopez-Lara IM, Sohlenkamp C. Amino acid-containing membrane lipids in bacteria. Prog Lipid Res. 2010;49:46–60. doi:10.1016/j.plipres.2009.08.002.
   PubMed Web of Science ®Google Scholar
• Dare K, Ibba M. Roles of tRNA in cell wall biosynthesis. Wiley Interdiscip Rev RNA. 2011;3:247–64. doi:10.1002/wrna.1108
   Web of Science ®Google Scholar
• Kuhn S, Slavetinsky CJ, Peschel A. Synthesis and function of phospholipids in Staphylococcus aureus. Int J Med Microbiol. 2015;305:196–202. doi:10.1016/j.ijmm.2014.12.016.
   PubMed Web of Science ®Google Scholar
• Hancock RE. Peptide antibiotics. Lancet. 1997;349:418–22. doi:10.1016/S0140-6736(97)80051-7.
   PubMed Web of Science ®Google Scholar
• Finking R, Marahiel MA. Biosynthesis of nonribosomal peptides. Annu Rev Microbiol. 2004;58:453–88. doi:10.1146/annurev.micro.58.030603.123615.
   PubMed Web of Science ®Google Scholar
• Hechard Y, Sahl HG. Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria. Biochimie. 2002;84:545–57. doi:10.1016/S0300-9084(02)01417-7.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay J, Sineva E, Knight J, Levy RM, Ebright RH. Antibacterial peptide microcin J25 inhibits transcription by binding within and obstructing the RNA polymerase secondary channel. Mol Cell. 2004;14:739–51. doi:10.1016/j.molcel.2004.06.010.
   PubMed Web of Science ®Google Scholar
• Mardirossian M, Grzela R, Giglione C, Meinnel T, Gennaro R, Mergaert P, Scocchi M. The host antimicrobial peptide Bac71-35 binds to bacterial ribosomal proteins and inhibits protein synthesis. Chem Biol. 2014;21:1639–47. doi:10.1016/j.chembiol.2014.10.009.
   PubMedGoogle Scholar
• Krizsan A, Volke D, Weinert S, Strater N, Knappe D, Hoffmann R. Insect-derived proline-rich antimicrobial peptides kill bacteria by inhibiting bacterial protein translation at the 70S ribosome. Angew Chem Int Ed Engl. 2014;53:12236–9. doi:10.1002/anie.201407145.
   PubMed Web of Science ®Google Scholar
• Hancock RE, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol. 2006;24:1551–7. doi:10.1038/nbt1267.
   PubMed Web of Science ®Google Scholar
• Peschel A, Sahl HG. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol. 2006;4:529–36. doi:10.1038/nrmicro1441.
   PubMed Web of Science ®Google Scholar
• Wang G, Li X, Wang Z. APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res. 2016;44:D1087–93. doi:10.1093/nar/gkv1278.
   PubMed Web of Science ®Google Scholar
• Wang G. Human antimicrobial peptides and proteins. Pharmaceuticals (Basel). 2014;7:545–94. doi:10.3390/ph7050545.
   PubMedGoogle Scholar
• Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009;30:131–41. doi:10.1016/j.it.2008.12.003.
   PubMed Web of Science ®Google Scholar
• Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta. 1999;1462:1–10. doi:10.1016/S0005-2736(99)00197-2.
   PubMed Web of Science ®Google Scholar
• Nawrocki KL, Crispell EK, McBride SM. Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria. Antibiotics (Basel). 2014;3:461–92. doi:10.3390/antibiotics3040461.
   PubMedGoogle Scholar
• Band VI, Weiss DS. Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria. Antibiotics (Basel). 2015;4:18–41. doi:10.3390/antibiotics4010018.
   PubMed Web of Science ®Google Scholar
• Luevano-Martinez LA, Kowaltowski AJ. Phosphatidylglycerol-derived phospholipids have a universal, domain-crossing role in stress responses. Arch Biochem Biophys. 2015;585:90–7. doi:10.1016/j.abb.2015.09.015.
   PubMed Web of Science ®Google Scholar
• Lennarz WJ, Bonsen PP, van Deenen LL. Substrate specificity of O-L-lysylphosphatidylglycerol synthetase. Enzymatic studies on the structure of O-L-lysylphosphatidylglycerol. Biochemistry (Mosc). 1967;6:2307–12
   Google Scholar
• Lennarz WJ, Nesbitt JA, 3rd, Reiss J. The participation of sRNA in the enzymatic synthesis of O-L-lysyl phosphatidylgylcerol in Staphylococcus aureus. Proc Natl Acad Sci U S A. 1966;55:934–41. doi:10.1073/pnas.55.4.934.
   PubMed Web of Science ®Google Scholar
• Peschel A, Collins LV. Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin. Peptides. 2001;22:1651–9. doi:10.1016/S0196-9781(01)00500-9.
   PubMed Web of Science ®Google Scholar
• Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med. 2001;193:1067–76. doi:10.1084/jem.193.9.1067.
   PubMed Web of Science ®Google Scholar
• Arendt W, Hebecker S, Jager S, Nimtz M, Moser J. Resistance phenotypes mediated by aminoacyl-phosphatidylglycerol synthases. J Bacteriol. 2012;194:1401–16. doi:10.1128/JB.06576-11.
   PubMed Web of Science ®Google Scholar
• Ernst CM, Kuhn S, Slavetinsky CJ, Krismer B, Heilbronner S, Gekeler C, Kraus D, Wagner S, Peschel A. The lipid-modifying multiple Peptide resistance factor is an oligomer consisting of distinct interacting synthase and flippase subunits. MBio. 2015;6.
   PubMed Web of Science ®Google Scholar
• Ernst CM, Peschel A. Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids. Mol Microbiol. 2011;80:290–9. doi:10.1111/j.1365-2958.2011.07576.x.
   PubMed Web of Science ®Google Scholar
• Ernst CM, Staubitz P, Mishra NN, Yang SJ, Hornig G, Kalbacher H, Bayer AS, Kraus D, Peschel A. The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS Pathog. 2009;5:e1000660. doi:10.1371/journal.ppat.1000660.
   PubMed Web of Science ®Google Scholar
• Slavetinsky CJ, Peschel A, Ernst CM. Alanyl-phosphatidylglycerol and lysyl-phosphatidylglycerol are translocated by the same MprF flippases and have similar capacities to protect against the antibiotic daptomycin in Staphylococcus aureus. Antimicrob Agents Chemother. 2012;56:3492–7. doi:10.1128/AAC.00370-12.
   PubMed Web of Science ®Google Scholar
• Maloney E, Stankowska D, Zhang J, Fol M, Cheng QJ, Lun S, Bishai WR, Rajagopalan M, Chatterjee D, Madiraju MV. The two-domain LysX protein of Mycobacterium tuberculosis is required for production of lysinylated phosphatidylglycerol and resistance to cationic antimicrobial peptides. PLoS Pathog. 2009;5:e1000534. doi:10.1371/journal.ppat.1000534.
   PubMed Web of Science ®Google Scholar
• Hebecker S, Krausze J, Hasenkampf T, Schneider J, Groenewold M, Reichelt J, Jahn D, Heinz DW, Moser J. Structures of two bacterial resistance factors mediating tRNA-dependent aminoacylation of phosphatidylglycerol with lysine or alanine. Proc Natl Acad Sci U S A. 2015;112:10691–6. doi:10.1073/pnas.1511167112.
   PubMed Web of Science ®Google Scholar
• Roy H, Ibba M. RNA-dependent lipid remodeling by bacterial multiple peptide resistance factors. Proc Natl Acad Sci U S A. 2008;105:4667–72. doi:10.1073/pnas.0800006105.
   PubMed Web of Science ®Google Scholar
• Roy H, Ibba M. Broad range amino acid specificity of RNA-dependent lipid remodeling by multiple peptide resistance factors. J Biol Chem. 2009;284:29677–83. doi:10.1074/jbc.M109.046367.
   PubMed Web of Science ®Google Scholar
• Atila M, Katselis G, Chumala P, Luo Y. Characterization of N-Succinylation of L-Lysylphosphatidylglycerol in Bacillus subtilis Using Tandem Mass Spectrometry. J Am Soc Mass Spectrom. 2016;27:1606–13. doi:10.1007/s13361-016-1455-4.
   PubMed Web of Science ®Google Scholar
• Atila M, Luo Y. Profiling and tandem mass spectrometry analysis of aminoacylated phospholipids in Bacillus subtilis. F1000Res. 2016;5:121. doi:10.12688/f1000research.7842.1.
   PubMedGoogle Scholar
• Smith AM, Harrison JS, Sprague KM, Roy H. A conserved hydrolase responsible for the cleavage of aminoacylphosphatidylglycerol in the membrane of Enterococcus faecium. J Biol Chem. 2013;288:22768–76. doi:10.1074/jbc.M113.484402.
   PubMed Web of Science ®Google Scholar
• Bao Y, Sakinc T, Laverde D, Wobser D, Benachour A, Theilacker C, Hartke A, Huebner J. Role of mprF1 and mprF2 in the pathogenicity of Enterococcus faecalis. PLoS ONE. 2012;7:e38458. doi:10.1371/journal.pone.0038458.
   PubMed Web of Science ®Google Scholar
• dos Santos Mota JM, den Kamp JA, Verheij HM, van Deenen LL. Phospholipids of Streptococcus faecalis. J Bacteriol. 1970;104:611–9.
   PubMed Web of Science ®Google Scholar
• Hebecker S, Arendt W, Heinemann IU, Tiefenau JH, Nimtz M, Rohde M, et al. Alanyl-phosphatidylglycerol synthase: mechanism of substrate recognition during tRNA-dependent lipid modification in Pseudomonas aeruginosa. Mol Microbiol. 2011;80:935–50.
   PubMed Web of Science ®Google Scholar
• Iyer LM, Abhiman S, Maxwell Burroughs A, Aravind L. Amidoligases with ATP-grasp, glutamine synthetase-like and acetyltransferase-like domains: synthesis of novel metabolites and peptide modifications of proteins. Mol Biosyst. 2009;5:1636–60. doi:10.1039/b917682a.
   PubMed Web of Science ®Google Scholar
• Aravind L, de Souza RF, Iyer LM. Predicted class-I aminoacyl tRNA synthetase-like proteins in non-ribosomal peptide synthesis. Biol Direct. 2010;5:48. doi:10.1186/1745-6150-5-48.
   PubMed Web of Science ®Google Scholar
• Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, Boursnell C, Pang N, Forslund K, Ceric G, Clements J, et al. The Pfam protein families database. Nucleic Acids Res. 2012;40:D290–301. doi:10.1093/nar/gkr1065.
   PubMed Web of Science ®Google Scholar
• Rohrer S, Berger-Bachi B. FemABX peptidyl transferases: a link between branched-chain cell wall peptide formation and beta-lactam resistance in gram-positive cocci. Antimicrob Agents Chemother. 2003;47:837–46. doi:10.1128/AAC.47.3.837-846.2003.
   PubMed Web of Science ®Google Scholar
• Vollmer W, Blanot D, de Pedro MA. Peptidoglycan structure and architecture. FEMS Microbiol Rev. 2008;32:149–67. doi:10.1111/j.1574-6976.2007.00094.x.
   PubMed Web of Science ®Google Scholar
• Tasaki T, Sriram SM, Park KS, Kwon YT. The N-end rule pathway. Annu Rev Biochem. 2012;81:261–89. doi:10.1146/annurev-biochem-051710-093308.
   PubMed Web of Science ®Google Scholar
• Garg RP, Qian XL, Alemany LB, Moran S, Parry RJ. Investigations of valanimycin biosynthesis: elucidation of the role of seryl-tRNA. Proc Natl Acad Sci U S A. 2008;105:6543–7. doi:10.1073/pnas.0708957105.
   PubMed Web of Science ®Google Scholar
• Bougioukou DJ, Mukherjee S, van der Donk WA. Revisiting the biosynthesis of dehydrophos reveals a tRNA-dependent pathway. Proc Natl Acad Sci U S A. 2013;110:10952–7. doi:10.1073/pnas.1303568110.
   PubMed Web of Science ®Google Scholar
• Zhang W, Ntai I, Kelleher NL, Walsh CT. tRNA-dependent peptide bond formation by the transferase PacB in biosynthesis of the pacidamycin group of pentapeptidyl nucleoside antibiotics. Proc Natl Acad Sci U S A. 2011;108:12249–53. doi:10.1073/pnas.1109539108.
   PubMed Web of Science ®Google Scholar
• Huang Z, Wang KA, van der Donk WA. New Insights into the Biosynthesis of Fosfazinomycin. Chem Sci. 2016;7:5219–23. doi:10.1039/C6SC01389A.
   PubMed Web of Science ®Google Scholar
• Maruyama C, Niikura H, Izumikawa M, Hashimoto J, Shin-Ya K, Komatsu M, Ikeda H, Kuroda M, Sekizuka T, Ishikawa J, et al. tRNA-Dependent Aminoacylation of an Amino Sugar Intermediate in the Biosynthesis of a Streptothricin-Related Antibiotic. Appl Environ Microbiol. 2016;82:3640–8. doi:10.1128/AEM.00725-16.
   PubMed Web of Science ®Google Scholar
• Fonvielle M, Li de La Sierra-Gallay I, El-Sagheer AH, Lecerf M, Patin D, Mellal D, Mayer C, Blanot D, Gale N, Brown T, et al. The structure of FemX(Wv) in complex with a peptidyl-RNA conjugate: mechanism of aminoacyl transfer from Ala-tRNA(Ala) to peptidoglycan precursors. Angew Chem Int Ed Engl. 2013;52:7278–81. doi:10.1002/anie.201301411.
   PubMed Web of Science ®Google Scholar
• Gutberlet T, Dietrich U, Bradaczek H, Pohlentz G, Leopold K, Fischer W. Cardiolipin, alpha-D-glucopyranosyl, and L-lysylcardiolipin from gram-positive bacteria: FAB MS, monofilm and X-ray powder diffraction studies. Biochim Biophys Acta. 2000;1463:307–22. doi:10.1016/S0005-2736(99)00214-X.
   PubMed Web of Science ®Google Scholar
• Fischer W, Leopold K. Polar lipids of four Listeria species containing L-lysylcardiolipin, a novel lipid structure, and other unique phospholipids. Int J Syst Bacteriol. 1999;2:653–62. doi:10.1099/00207713-49-2-653
   Google Scholar
• Thedieck K, Hain T, Mohamed W, Tindall BJ, Nimtz M, Chakraborty T, Wehland J, Jänsch L. The MprF protein is required for lysinylation of phospholipids in listerial membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes. Mol Microbiol. 2006;62:1325–39. doi:10.1111/j.1365-2958.2006.05452.x.
   PubMed Web of Science ®Google Scholar
• Dare K, Shepherd J, Roy H, Seveau S, Ibba M. LysPGS formation in Listeria monocytogenes has broad roles in maintaining membrane integrity beyond antimicrobial peptide resistance. Virulence. 2014;5:534–46. doi:10.4161/viru.28359.
   PubMed Web of Science ®Google Scholar
• Smith AM, Harrison JS, Grube CD, Sheppe AE, Sahara N, Ishii R, Nureki O, Roy H. tRNA-dependent alanylation of diacylglycerol and phosphatidylglycerol in Corynebacterium glutamicum. Mol Microbiol. 2015;98:681–93. doi:10.1111/mmi.13150.
   PubMed Web of Science ®Google Scholar
• Arendt W, Groenewold MK, Hebecker S, Dickschat JS, Moser J. Identification and characterization of a periplasmic aminoacyl-phosphatidylglycerol hydrolase responsible for Pseudomonas aeruginosa lipid homeostasis. J Biol Chem. 2013;288:24717–30. doi:10.1074/jbc.M113.482935.
   PubMed Web of Science ®Google Scholar
• Zhang X, Paganelli FL, Bierschenk D, Kuipers A, Bonten MJ, Willems RJ, van Schaik W. Genome-Wide Identification of Ampicillin Resistance Determinants in Enterococcus faecium. PLoS Genet. 2012;8:e1002804. doi:10.1371/journal.pgen.1002804.
   PubMed Web of Science ®Google Scholar
• Samant S, Hsu FF, Neyfakh AA, Lee H. The Bacillus anthracis protein MprF is required for synthesis of lysylphosphatidylglycerols and for resistance to cationic antimicrobial peptides. J Bacteriol. 2009;191:1311–9. doi:10.1128/JB.01345-08.
   PubMed Web of Science ®Google Scholar
• Klein S, Lorenzo C, Hoffmann S, Walther JM, Storbeck S, Piekarski T, Tindall BJ, Wray V, Nimtz M, Moser J. Adaptation of Pseudomonas aeruginosa to various conditions includes tRNA-dependent formation of alanyl-phosphatidylglycerol. Mol Microbiol. 2009;71:551–65. doi:10.1111/j.1365-2958.2008.06562.x.
   PubMed Web of Science ®Google Scholar
• Vandal OH, Roberts JA, Odaira T, Schnappinger D, Nathan CF, Ehrt S. Acid-susceptible mutants of Mycobacterium tuberculosis share hypersusceptibility to cell wall and oxidative stress and to the host environment. J Bacteriol. 2009;191:625–31. doi:10.1128/JB.00932-08.
   PubMed Web of Science ®Google Scholar
• Kumariya R, Sood SK, Rajput YS, Saini N, Garsa AK. Increased membrane surface positive charge and altered membrane fluidity leads to cationic antimicrobial peptide resistance in Enterococcus faecalis. Biochim Biophys Acta. 2015;1848:1367–75. doi:10.1016/j.bbamem.2015.03.007.
   PubMed Web of Science ®Google Scholar
• Hachmann AB, Angert ER, Helmann JD. Genetic analysis of factors affecting susceptibility of Bacillus subtilis to daptomycin. Antimicrob Agents Chemother. 2009;53:1598–609. doi:10.1128/AAC.01329-08.
   PubMed Web of Science ®Google Scholar
• Salzberg LI, Helmann JD. Phenotypic and transcriptomic characterization of Bacillus subtilis mutants with grossly altered membrane composition. J Bacteriol. 2008;190:7797–807.
   Web of Science ®Google Scholar
• Komatsuzawa H, Ohta K, Fujiwara T, Choi GH, Labischinski H, Sugai M. Cloning and sequencing of the gene, fmtC, which affects oxacillin resistance in methicillin-resistant Staphylococcus aureus. FEMS Microbiol Lett. 2001;203:49–54. doi:10.1111/j.1574-6968.2001.tb10819.x.
   PubMed Web of Science ®Google Scholar
• Nishi H, Komatsuzawa H, Fujiwara T, McCallum N, Sugai M. Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus. Antimicrob Agents Chemother. 2004;48:4800–7. doi:10.1128/AAC.48.12.4800-4807.2004.
   PubMed Web of Science ®Google Scholar
• Ruzin A, Severin A, Moghazeh SL, Etienne J, Bradford PA, Projan SJ, Shlaes DM. Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus. Biochim Biophys Acta. 2003;1621:117–21. doi:10.1016/S0304-4165(03)00028-X.
   PubMed Web of Science ®Google Scholar
• Sievers S, Ernst CM, Geiger T, Hecker M, Wolz C, Becher D, Peschel A. Changing the phospholipid composition of Staphylococcus aureus causes distinct changes in membrane proteome and membrane-sensory regulators. Proteomics. 2010;10:1685–93. doi:10.1002/pmic.200900772.
   PubMed Web of Science ®Google Scholar
• Zemansky J, Kline BC, Woodward JJ, Leber JH, Marquis H, Portnoy DA. Development of a mariner-based transposon and identification of Listeria monocytogenes determinants, including the peptidyl-prolyl isomerase PrsA2, that contribute to its hemolytic phenotype. J Bacteriol. 2009;191:3950–64. doi:10.1128/JB.00016-09.
   PubMed Web of Science ®Google Scholar
• Weidenmaier C, Peschel A, Kempf VA, Lucindo N, Yeaman MR, Bayer AS. DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model. Infect Immun. 2005;73:8033–8. doi:10.1128/IAI.73.12.8033-8038.2005.
   PubMed Web of Science ®Google Scholar
• Kristian SA, Durr M, Van Strijp JA, Neumeister B, Peschel A. MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing. Infect Immun. 2003;71:546–9. doi:10.1128/IAI.71.1.546-549.2003.
   PubMed Web of Science ®Google Scholar
• Fol M, Globinska A, Staczek P, Kowalewicz-Kulbat M, Druszczynska M, Madiraju MV, Rudnicka W. The lack of L-PG production and the repercussions of it in regards to M. tuberculosis interactions with mononuclear phagocytes. Acta Microbiol Immunol Hung. 2013;60:127–44. doi:10.1556/AMicr.60.2013.2.4
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Suzuki S, Okamura S, Miura Y, Tsukimori A, Nakamura I, Ito N, Masuya A, Shiina T, Matsumoto T. Evolution and single-nucleotide polymorphisms in methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin and daptomycin, based on determination of the complete genome. Antimicrob Agents Chemother. 2015;59:3585–7. doi:10.1128/AAC.05159-14.
   PubMed Web of Science ®Google Scholar
• Chen CJ, Huang YC, Chiu CH. Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia. J Antimicrob Chemother. 2015;70:2965–72.
   Web of Science ®Google Scholar
• Cameron DR, Jiang JH, Abbott IJ, Spelman DW, Peleg AY. Draft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210. Genome Announc. 2015;3.
   Google Scholar
• Bayer AS, Mishra NN, Chen L, Kreiswirth BN, Rubio A, Yang SJ. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides. Antimicrob Agents Chemother. 2015;59:4930–7. doi:10.1128/AAC.00970-15.
   PubMed Web of Science ®Google Scholar
• Baek KT, Thogersen L, Mogenssen RG, Mellergaard M, Thomsen LE, Petersen A, et al. Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene. Antimicrob Agents Chemother. 2015;59:6983–91.
   PubMed Web of Science ®Google Scholar
• Yang SJ, Mishra NN, Rubio A, Bayer AS. Causal role of single nucleotide polymorphisms within the mprF gene of Staphylococcus aureus in daptomycin resistance. Antimicrob Agents Chemother. 2013;57:5658–64. doi:10.1128/AAC.01184-13.
   PubMed Web of Science ®Google Scholar
• Mishra NN, Yang SJ, Chen L, Muller C, Saleh-Mghir A, Kuhn S, Peschel A, Yeaman MR, Nast CC, Kreiswirth BN, et al. Emergence of daptomycin resistance in daptomycin-naive rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms. PLoS ONE. 2013;8:e71151. doi:10.1371/journal.pone.0071151.
   PubMed Web of Science ®Google Scholar
• Patel D, Husain M, Vidaillac C, Steed ME, Rybak MJ, Seo SM, Kaatz GW. Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus. Int J Antimicrob Agents. 2011;38:442–6. doi:10.1016/j.ijantimicag.2011.06.010.
   PubMed Web of Science ®Google Scholar
• Friedman L, Alder JD, Silverman JA. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob Agents Chemother. 2006;50:2137–45. doi:10.1128/AAC.00039-06.
   PubMed Web of Science ®Google Scholar
• Julian K, Kosowska-Shick K, Whitener C, Roos M, Labischinski H, Rubio A, Parent L, Ednie L, Koeth L, Bogdanovich T, et al. Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis. Antimicrob Agents Chemother. 2007;51:3445–8. doi:10.1128/AAC.00559-07.
   PubMed Web of Science ®Google Scholar
• Pillai SK, Gold HS, Sakoulas G, Wennersten C, Moellering RC, Jr., Eliopoulos GM. Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF. Antimicrob Agents Chemother. 2007;51:2223–5. doi:10.1128/AAC.00202-07.
   PubMed Web of Science ®Google Scholar
• Murthy MH, Olson ME, Wickert RW, Fey PD, Jalali Z. Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate. J Med Microbiol. 2008;57:1036–8. doi:10.1099/jmm.0.2008/000588-0.
   PubMed Web of Science ®Google Scholar
• Pardieu C, Casali N, Clark SO, Hooper R, Williams A, Velji P, Gonzalo X, Drobniewski F. Correlates between models of virulence for Mycobacterium tuberculosis among isolates of the Central Asian lineage: a case for lysozyme resistance testing? Infect Immun. 2015;83:2213–23. doi:10.1128/IAI.03080-14.
   PubMed Web of Science ®Google Scholar
• Nishibori A, Kusaka J, Hara H, Umeda M, Matsumoto K. Phosphatidylethanolamine domains and localization of phospholipid synthases in Bacillus subtilis membranes. J Bacteriol. 2005;187:2163–74. doi:10.1128/JB.187.6.2163-2174.2005.
   PubMed Web of Science ®Google Scholar
• Kandaswamy K, Liew TH, Wang CY, Huston-Warren E, Meyer-Hoffert U, Hultenby K, Schröder JM, Caparon MG, Normark S, Henriques-Normark B, et al. Focal targeting by human beta-defensin 2 disrupts localized virulence factor assembly sites in Enterococcus faecalis. Proc Natl Acad Sci U S A. 2013;110:20230–5. doi:10.1073/pnas.1319066110.
   PubMed Web of Science ®Google Scholar
• Ichihashi N, Kurokawa K, Matsuo M, Kaito C, Sekimizu K. Inhibitory effects of basic or neutral phospholipid on acidic phospholipid-mediated dissociation of adenine nucleotide bound to DnaA protein, the initiator of chromosomal DNA replication. J Biol Chem. 2003;278:28778–86. doi:10.1074/jbc.M212202200.
   PubMed Web of Science ®Google Scholar
• Haest CW, de Gier J, den Kamp JO, Bartels P, van Deenen LL. Changes in permeability of Staphylococcus aureus and derived liposomes with varying lipid composition. Biochim Biophys Acta. 1972;255:720–33. doi:10.1016/0005-2736(72)90385-9.
   PubMed Web of Science ®Google Scholar
• den Kamp JO, Houtsmuller UM, van Deenen LL. On the phospholipids of Bacillus megaterium. Biochim Biophys Acta. 1965;106:438–41. doi:10.1016/0005-2760(65)90059-7.
   PubMed Web of Science ®Google Scholar
• Maloney E, Lun S, Stankowska D, Guo H, Rajagoapalan M, Bishai WR, Madiraju MV. Alterations in phospholipid catabolism in Mycobacterium tuberculosis lysX mutant. Front Microbiol. 2011;2:19. doi:10.3389/fmicb.2011.00019.
   PubMed Web of Science ®Google Scholar
• den Kamp JA, Redai I, van Deenen LL. Phospholipid composition of Bacillus subtilis. J Bacteriol. 1969;99:298–303.
   PubMed Web of Science ®Google Scholar
• van Iterson W, den Kamp JA. Bacteria-shaped gymnoplasts (protoplasts) of Bacillus subtilis. J Bacteriol. 1969;99:304–15.
   PubMed Web of Science ®Google Scholar
• Houtsmuller UM, Van D. On the Accumulation of Amino Acid Derivatives of Phosphatidylglycerol in Bacteria. Biochim Biophys Acta. 1964;84:96–8.
   PubMed Web of Science ®Google Scholar
• Houtsmuller UM, van Deenen LL. On the amino acid esters of phosphatidyl glycerol from bacteria. Biochim Biophys Acta. 1965;106:564–76. doi:10.1016/0005-2760(65)90072-X.
   PubMed Web of Science ®Google Scholar
• Kocun FJ. Amino acid containing phospholipids as major components of the phospholipids of Streptococcus faecalis 10C1. Biochim Biophys Acta. 1970;202:277–82. doi:10.1016/0005-2760(70)90189-X.
   PubMedGoogle Scholar
• Gould RM, Lennarz WJ. Metabolism of phosphatidylglycerol and lysyl-phosphatidylglycerol in Staphylococcus aureus. J Bacteriol. 1970;104:1135–44.
   PubMed Web of Science ®Google Scholar
• Rubin HE, Nerad T, Vaughan F. Lactate acid inhibition of Salmonella typhimurium in yogurt. J Dairy Sci. 1982;65:197–203. doi:10.3168/jds.S0022-0302(82)82177-2.
   PubMed Web of Science ®Google Scholar
• Hebeler BH, Chatterjee AN, Young FE. Regulation of the bacterial cell wall: effect of antibiotics on lipid biosynthesis. Antimicrob Agents Chemother. 1973;4:346–53. doi:10.1128/AAC.4.3.346.
   PubMed Web of Science ®Google Scholar
• Rozgonyi F, Kiss J, Jekel P, Vaczi L. Effect of methicillin on the phospholipid content of methicillin sensitive Staphylococcus aureus. Acta Microbiol Acad Sci Hung. 1980;27:31–40.
   PubMedGoogle Scholar
• Rozgonyi F, Biacs P, Szitha K, Kiss J. Effect of methicillin on the fatty acid composition of phospholipids in methicillin sensitive Staphylococcus aureus. Acta Microbiol Acad Sci Hung. 1981;28:97–110.
   PubMedGoogle Scholar
• Yang SJ, Xiong YQ, Yeaman MR, Bayles KW, Abdelhady W, Bayer AS. Role of the LytSR two-component regulatory system in adaptation to cationic antimicrobial peptides in Staphylococcus aureus. Antimicrob Agents Chemother. 2013;57:3875–82. doi:10.1128/AAC.00412-13.
   PubMed Web of Science ®Google Scholar
• Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol. 2007;66:1136–47. doi:10.1111/j.1365-2958.2007.05986.x.
   PubMed Web of Science ®Google Scholar
• Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M. Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci U S A. 2007;104:9469–74. doi:10.1073/pnas.0702159104.
   PubMed Web of Science ®Google Scholar
• Yang SJ, Bayer AS, Mishra NN, Meehl M, Ledala N, Yeaman MR, Xiong YQ, Cheung AL. The Staphylococcus aureus Two-Component Regulatory System, GraRS, Senses and Confers Resistance to Selected Cationic Antimicrobial Peptides. Infect Immun. 2012;80:74–81. doi:10.1128/IAI.05669-11.
   PubMed Web of Science ®Google Scholar
• Hiron A, Falord M, Valle J, Debarbouille M, Msadek T. Bacitracin and nisin resistance in Staphylococcus aureus: a novel pathway involving the BraS/BraR two-component system (SA2417/SA2418) and both the BraD/BraE and VraD/VraE ABC transporters. Mol Microbiol. 2011;81:602–22. doi:10.1111/j.1365-2958.2011.07735.x.
   PubMed Web of Science ®Google Scholar
• Cheung AL, Bayer AS, Yeaman MR, Xiong YQ, Waring AJ, Memmi G, Donegan N, Chaili S, Yang SJ. Site-specific mutation of the sensor kinase GraS in Staphylococcus aureus alters the adaptive response to distinct cationic antimicrobial peptides. Infect Immun. 2014;82:5336–45. doi:10.1128/IAI.02480-14.
   PubMed Web of Science ®Google Scholar
• Falord M, Karimova G, Hiron A, Msadek T. GraXSR proteins interact with the VraFG ABC transporter to form a five-component system required for cationic antimicrobial peptide sensing and resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2012;56:1047–58. doi:10.1128/AAC.05054-11.
   PubMed Web of Science ®Google Scholar
• Werth BJ, Sakoulas G, Rose WE, Pogliano J, Tewhey R, Rybak MJ. Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother. 2013;57:66–73. doi:10.1128/AAC.01586-12.
   PubMed Web of Science ®Google Scholar
• Berti AD, Baines SL, Howden BP, Sakoulas G, Nizet V, Proctor RA, Rose WE. Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics. Antimicrob Agents Chemother. 2015;59:2799–806. doi:10.1128/AAC.04990-14.
   PubMed Web of Science ®Google Scholar
• Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci U S A. 2000;97:1433–7. doi:10.1073/pnas.030540597.
   PubMed Web of Science ®Google Scholar
• Kourtesi C, Ball AR, Huang YY, Jachak SM, Vera DM, Khondkar P, Gibbons S, Hamblin MR, Tegos GP. Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation. Open Microbiol J. 2013;7:34–52. doi:10.2174/1874285801307010034.
   PubMedGoogle Scholar
• Lomovskaya O, Bostian KA. Practical applications and feasibility of efflux pump inhibitors in the clinic–a vision for applied use. Biochem Pharmacol. 2006;71:910–8. doi:10.1016/j.bcp.2005.12.008.
   PubMed Web of Science ®Google Scholar
• Grube CD, Roy H. A Quantitative Spectrophotometric Assay to Monitor the tRNA-Dependent Pathway for Lipid Aminoacylation In Vitro. J Biomol Screen. 2016. doi:10.1177/1087057116642987.
   PubMedGoogle Scholar
• Rubio A, Conrad M, Haselbeck R, Kedar GC, Driver V, Finn J, et al. Regulation of mprF by antisense restores daptomycin susceptibility to daptomycin-resistant isolates of Staphylococcus aureus. Antimicrob Agents Chemother. 2010.
   PubMed Web of Science ®Google Scholar
• Mishra A, Apeksha B, Koppolu P, Lingam SA. Role of antimicrobial peptides in periodontal innate defense mechanism. J Oral Res Rev. 2015;7:74–6. doi:10.4103/2249-4987.172500
   Google Scholar
• Hankins JV, Madsen JA, Giles DK, Brodbelt JS, Trent MS. Amino acid addition to Vibrio cholerae LPS establishes a link between surface remodeling in gram-positive and gram-negative bacteria. Proc Natl Acad Sci U S A. 2012;109:8722–7. doi:10.1073/pnas.1201313109.
   PubMed Web of Science ®Google Scholar
• Henderson JC, Fage CD, Cannon JR, Brodbelt JS, Keatinge-Clay AT, Trent MS. Antimicrobial peptide resistance of Vibrio cholerae results from an LPS modification pathway related to nonribosomal peptide synthetases. ACS Chem Biol. 2014;9:2382–92. doi:10.1021/cb500438x.
   PubMed Web of Science ®Google Scholar
• Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. 2014;5:643. doi:10.3389/fmicb.2014.00643.
   PubMed Web of Science ®Google Scholar